What is the recommended management of diabetic ketoacidosis according to the Kitabchi guidelines?

Management of Diabetic Ketoacidosis Based on Kitabchi Guidelines

For moderate to severe DKA, initiate continuous intravenous regular insulin at a fixed rate of 0.1 units/kg/h without a bolus, combined with aggressive fluid resuscitation using isotonic saline, and monitor venous pH and blood ketones every 2-4 hours until resolution criteria are met (glucose <200 mg/dL, bicarbonate ≥18 mEq/L, venous pH >7.3). 1

Initial Assessment and Diagnosis

Upon presentation, immediately obtain venous blood gases, serum electrolytes, glucose, BUN, creatinine, calcium, phosphorus, and urinalysis. 1 Arterial blood gases are generally unnecessary; venous pH (typically 0.03 units lower than arterial) and anion gap adequately monitor acidosis resolution. 1

Critical diagnostic criteria include:

• Blood glucose typically >250 mg/dL (though euglycemic DKA can occur, especially with SGLT2 inhibitor use) 2
• Venous pH <7.3 1
• Serum bicarbonate <15 mEq/L 1
• Elevated blood ketones (β-hydroxybutyrate is preferred over nitroprusside method) 1

Fluid Resuscitation

Begin with isotonic saline (0.9% NaCl) at 15-20 mL/kg/h (approximately 1-1.5 L) during the first hour. 1 Subsequent fluid rates should be 1.5 times the 24-hour maintenance requirements (approximately 5 mL/kg/h), not exceeding twice maintenance. 1

Adjust fluid type based on corrected serum sodium and hemodynamic status to avoid cerebral edema from overly rapid osmolality correction. 1 In patients with heart failure, renal disease, or older age, more cautious fluid administration is warranted. 3

Insulin Therapy

For Moderate to Severe DKA:

Continuous intravenous regular insulin at 0.1 units/kg/h is preferred (Grade B recommendation). 1 Do not give an initial bolus in the modern protocol approach. 1

For Mild DKA:

Subcutaneous or intramuscular regular insulin is equally effective. 1 Give a priming dose of 0.4-0.6 units/kg (half IV bolus, half SC/IM), then 0.1 units/kg/h SC or IM. 1

Critical insulin management points:

• When glucose falls below 14 mmol/L (252 mg/dL), add 10% dextrose infusion and consider reducing insulin to 0.05 units/kg/h to prevent hypoglycemia. 4, 5
• Continue long-acting insulin analogues (glargine, detemir) at usual doses if already prescribed. 6
• Never abruptly discontinue IV insulin; overlap with subcutaneous insulin for 1-2 hours to prevent rebound hyperglycemia. 1

Electrolyte Management

Potassium:

Begin potassium replacement as soon as urine output is established and serum potassium is <5.3 mEq/L. 1 Use a combination of 1/3 potassium phosphate and 2/3 potassium chloride or acetate. 1 Hypokalaemia is a common complication requiring vigilant monitoring. 4, 5

Phosphate:

Routine phosphate replacement has not shown clinical benefit (Grade A evidence). 1 However, consider careful replacement when serum phosphate is <1.0 mg/dL in patients with cardiac dysfunction, anemia, respiratory depression, or severe hypophosphatemia to avoid muscle weakness. 1

Bicarbonate:

Bicarbonate therapy is only indicated when pH <6.9 (Grade C recommendation). 1 If pH remains <7.0 after initial hydration, administer 1-2 mEq/kg sodium bicarbonate over 1 hour. 1 Bicarbonate is not necessary when pH ≥7.0. 1

Monitoring

Draw blood every 2-4 hours for electrolytes, glucose, BUN, creatinine, osmolality, and venous pH. 1

Preferred monitoring method is bedside capillary blood ketone measurement using a ketone meter. 6 The nitroprusside method (measuring acetoacetate and acetone) should not be used to assess treatment response because β-hydroxybutyrate—the predominant ketone in DKA—is not detected, and its conversion to acetoacetate during treatment falsely suggests worsening ketosis. 1

Resolution Criteria

DKA is resolved when ALL of the following are met:

• Glucose <200 mg/dL 1
• Serum bicarbonate ≥18 mEq/L 1
• Venous pH >7.3 1

Transition to Subcutaneous Insulin

Once DKA resolves and the patient can eat, initiate a multiple-dose subcutaneous regimen combining rapid-acting and long-acting insulin. 1 Continue IV insulin for 1-2 hours after starting subcutaneous insulin to maintain adequate plasma insulin levels. 1

If the patient remains NPO after resolution, continue IV insulin and supplement with subcutaneous regular insulin every 4 hours: give 5-unit increments for every 50 mg/dL above 150 mg/dL, up to 20 units for glucose ≥300 mg/dL. 1

Special Considerations

SGLT2 Inhibitor-Associated DKA:

Recognize that SGLT2 inhibitors increase the risk of euglycemic DKA (normal or near-normal glucose with ketoacidosis). 4, 7, 2 Discontinue these medications perioperatively and during acute illness. 7

End-Stage Renal Disease:

Patients on dialysis require modified fluid and electrolyte management. 4 Standard protocols may lead to volume overload.

Cerebral Edema Prevention:

Gradual correction of glucose and osmolality is essential (Grade C recommendation). 1 Use isotonic or hypotonic saline judiciously based on corrected serum sodium and hemodynamic status. 1

Common Pitfalls

Delayed insulin rate reduction when glucose <14 mmol/L leads to persistent hypoglycemia risk. 5 Studies show a median 3.2-hour delay in adjusting insulin despite guideline recommendations. 5

Premature discontinuation of IV insulin without adequate subcutaneous overlap causes rebound hyperglycemia and poor glycemic control. 1

Using urinary ketones or nitroprusside-based serum ketone assays misleads clinicians about treatment response. 1